BRADLEY PHARMACEUTICALS INC
CONSENT AND AGREEMENT
<DOCUMENT>
<TYPE>EX-10.4.4
<SEQUENCE>6
<FILENAME>e18698ex10-4_4.htm
<DESCRIPTION>CONSENT AND AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>

<!-- MARKER FORMAT-SHEET="Right Head Bold" FSL="Workstation" -->
<P ALIGN=Right><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>Exhibit 10.4.4 </B></FONT></P>


<!-- MARKER FORMAT-SHEET="Para Flush 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Confidential portions of this
document have been omitted and filed separately with the Commission. The omitted portions
have been marked as follows: &#147;***&#148;. </FONT></P>


<!-- MARKER FORMAT-SHEET="Center Head 2 Bold" FSL="Workstation" -->
<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>CONSENT AND AGREEMENT </B></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Consent and Agreement (this &#147;Agreement&#148;) is entered into as of July 9, 2004 between Par
Pharmaceutical, Inc. (&#147;Par&#148;) and Quintiles Ireland Limited (&#147;QIreland&#148;). </FONT></P>

<!-- MARKER FORMAT-SHEET="Center Head 2 no bold" FSL="Workstation" -->
<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2><u>Recitals</u> </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A.
  Par and Bioglan Pharma Inc. (now known as BPI New Corp., &#147;BPI&#148;) entered
  into the Distribution Agreement dated December 27, 2000 (the &#147;Original
  Agreement&#148;) regarding a pharmaceutical product currently marketed in the
  United States as Adoxa<sup>&reg;</sup>; </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.
Par, BPl and QIreland entered into the Assignment of Distribution Agreement dated March
22, 2002 (the &#147;First Amendment&#148;), pursuant to which BPI assigned to QIreland the Original
Agreement, and the parties amended certain provisions of the Original Agreement; </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C.
Par and QIreland entered into the Second Amendment to Distribution Agreement and First
Amendment to Assignment of Distribution Agreement dated September 11, 2003 (the &#147;Second
Amendment&#148;); </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D.
Par and QIreland entered into the Third Amendment to Distribution Agreement dated April
13, 2004 (the &#147;Third Amendment&#148;) (the Original Agreement, as amended by the First
Amendment, the Second Amendment and the Third Amendment, is referred to in this Agreement
as the &#147;Distribution Agreement&#148;); </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E.
QIreland and Bioglan Pharmaceuticals Company, an affiliate of QIreland, plan to transfer
and sell certain assets (the &#147;Sale&#148;) to BDY Acquisition Corp., a Delaware corporation and
wholly owned subsidiary of Bradley Pharmaceuticals, Inc., a Delaware corporation listed
on the New York Stock Exchange (the &#147;Buyer&#148;); </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;F.
In connection with the Sale, QIreland has requested, in accordance with Section 11.8 of
the Distribution Agreement, that Par consent to the transfer of the Distribution
Agreement to the Buyer and agree to certain matters as set forth in this Agreement; and </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;G.
Par has determined that such consent and agreement would benefit Par and accordingly Par
wishes to consent and agree to the transfer of the Distribution Agreement to Buyer and to
such other matters as are set forth in this Agreement. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW,
THEREFORE, the parties agree as follows: </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)
Par hereby consents, acknowledges and agrees that: </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent new" FSL="Project" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)
  QIreland may assign and transfer all of its rights and obligations under the
  Distribution Agreement to the Buyer. Upon the effective date of such assignment
  and transfer (the &#147;Assignment Date&#148;): </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Hang 10" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Times New Roman, Times, Serif" SIZE=2> &nbsp; </FONT></TD>
<TD WIDTH=5%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
                           (i)  </FONT></TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>the
Buyer shall be responsible for all                                     obligations under
the Distribution                                     Agreement, arising after the
Assignment                                     Date; </FONT></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Page Break CENTER" FSL="Workstation" -->
<BR>
<TABLE WIDTH=100%><TR><TD WIDTH=20% ALIGN=left><FONT SIZE=1>&nbsp;</FONT></TD><TD WIDTH=60% ALIGN=center><FONT SIZE="2">
</FONT></TD><TD WIDTH=20% ALIGN=right><FONT SIZE="1">&nbsp;</FONT></TD></TR></TABLE><HR ALIGN=LEFT WIDTH=100% SIZE=5 noshade><BR>





<!-- *************************************************************************** -->
<!-- MARKER PAGE="sheet: 6; page: 6" -->

<!-- MARKER FORMAT-SHEET="Para Hang 10" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Times New Roman, Times, Serif" SIZE=2> &nbsp; </FONT></TD>
<TD WIDTH=5%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
                          (ii)  </FONT></TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>the
Buyer shall have and enjoy all the rights                                   and benefits
of QIreland under the                                   Distribution Agreement; </FONT></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Hang 10" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Times New Roman, Times, Serif" SIZE=2> &nbsp; </FONT></TD>
<TD WIDTH=5%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
                         (iii)  </FONT></TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>QIreland
shall have no responsibility for any                                   obligations under
the Distribution Agreement                                   arising after the Assignment
Date; and </FONT></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Hang 10" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Times New Roman, Times, Serif" SIZE=2> &nbsp; </FONT></TD>
<TD WIDTH=5%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
                          (iv)  </FONT></TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>QIreland
shall cease to be a party, and Buyer                                   shall become a
party, to the Distribution                                   Agreement with respect to
all obligations                                   under the Distribution Agreement
arising after                                   the Assignment Date; </FONT></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Indent new" FSL="Project" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)
Notwithstanding Section 11.8 of the Original Agreement, the Buyer shall be entitled to
assign and transfer any and all of its rights and obligations under the Distribution
Agreement, without Par&#146;s consent, to an affiliate of the Buyer, but no such assignment or
transfer shall relieve the Buyer of any of, and the Buyer shall remain responsible for,
its obligations under the Distribution Agreement; </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent new" FSL="Project" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)
Prior to or on the Assignment Date, QIreland may assign or transfer any and all of its
rights and obligations under the Distribution Agreement to an affiliate of QIreland and
such party or parties may assign or transfer such rights and obligations to the Buyer,
which shall have the same effect as if QIreland had assigned such rights and obligations
to the Buyer as described in Section 1(a) above; and </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent new" FSL="Project" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)
The Distribution Agreement constitutes all of the agreements, arrangements or
understandings with respect to the subject matter thereof; the Distribution Agreement has
not been amended or modified; the Distribution Agreement is in full force and effect and,
to the knowledge of Par, QIreland is in compliance with the Distribution Agreement and no
breach or default has occurred thereunder, and no event has occurred and no circumstance
exists that, with the passage or lapse of time or the giving of notice, or both, would
constitute a breach or default. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)
Prior to or following the Assignment Date, each party agrees to execute and deliver such
other agreements, documents and instruments, and to do and take such other acts or
actions, as any other party to this Agreement shall request for the purpose of carrying
out the intent of this Agreement, including without limitation in order to carry out or
further evidence the assignment and transfer of all of QIreland&#146;s right, title and
interest in, to and under the Distribution Agreement to the Buyer. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)
This Agreement shall be binding upon the parties hereto and their successors and assigns
and shall inure to the benefit of such parties and their permitted successors and
assigns. This Agreement is also intended for the benefit of the Buyer, and the Buyer is
an intended third-party beneficiary of this Agreement. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)
This Agreement may be executed in any number of counterparts, each of which when executed
and delivered shall be deemed to be an original and all of which counterparts taken
together should constitute one and the same instrument. The exchange of copies of this
Agreement and of executed signature pages by facsimile transmission or by email
transmission in portable digital format, or similar format, shall constitute effective
execution and delivery of </FONT></P>

<!-- MARKER FORMAT-SHEET="Page Break CENTER" FSL="Workstation" -->
<BR>
<TABLE WIDTH=100%><TR><TD WIDTH=20% ALIGN=left><FONT SIZE=1>&nbsp;</FONT></TD><TD WIDTH=60% ALIGN=center><FONT SIZE="2">
2</FONT></TD><TD WIDTH=20% ALIGN=right><FONT SIZE="1">&nbsp;</FONT></TD></TR></TABLE><HR ALIGN=LEFT WIDTH=100% SIZE=5 noshade><BR>





<!-- *************************************************************************** -->
<!-- MARKER PAGE="sheet: 7; page: 7" -->

<!-- MARKER FORMAT-SHEET="Para Flush 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>this Agreement. Signatures of the
parties transmitted by facsimile, or by email in portable digital or similar format shall
be deemed to be their original signatures for all purposes. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)
Each party to this Agreement represents and warrants to the other party that: (a) it is
duly organized, validly existing, and in good standing under the laws of the jurisdiction
in which it is organized, with full corporate power and authority to execute, deliver and
perform this Agreement; and (b) this Agreement constitutes the legal, valid and binding
obligation of it, enforceable against it in accordance with the terms of this Agreement. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)
In consideration for Par consenting to the assignment and transfer of the Distribution
Agreement to Buyer and agreeing to the other matters set forth in this Agreement,
Quintiles agrees to pay, either directly or through an affiliate, to Par a fee of  ***  within three (3) business days after the
date of the closing of the Sale. </FONT></P>

<!-- MARKER FORMAT-SHEET="Center Head 2 no bold" FSL="Workstation" -->
<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE="2"><I>[signature page follows]</I> </FONT> </P>

<!-- MARKER FORMAT-SHEET="Page Break CENTER" FSL="Workstation" -->
<BR>
<TABLE WIDTH=100%><TR><TD WIDTH=20% ALIGN=left><FONT SIZE=1>&nbsp;</FONT></TD><TD WIDTH=60% ALIGN=center><FONT SIZE="2">
3</FONT></TD><TD WIDTH=20% ALIGN=right><FONT SIZE="1">&nbsp;</FONT></TD></TR></TABLE><HR ALIGN=LEFT WIDTH=100% SIZE=5 noshade><BR>





<!-- *************************************************************************** -->
<!-- MARKER PAGE="sheet: 8; page: 8" -->

<!-- MARKER FORMAT-SHEET="Center Head 2 no bold" FSL="Workstation" -->
<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE="2"><I>[Signature page to
Consent and Agreement]</I> </FONT> </P>

<!-- MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN
WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of
the date first set forth above. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush 20" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
  <TR VALIGN=TOP>
    <TD WIDTH=47%>&nbsp;</TD>
    <TD colspan="2"><FONT FACE="Times New Roman, Times, Serif" SIZE=2> </FONT>
      <p><FONT FACE="Times New Roman, Times, Serif" SIZE=2> PAR PHARMACEUTICAL,
        INC. </FONT></p>
      <p>&nbsp;</p>
    </TD>
  </TR>
  <TR VALIGN=TOP>
    <TD WIDTH=47%>&nbsp;</TD>
    <TD WIDTH=4%><font face="Times New Roman, Times, Serif" size=2>By:</font></TD>
    <TD WIDTH=49%>
      <p><font face="Times New Roman, Times, Serif" size=2>/s/ Dennis O&#146;Conner</font>
      <hr noshade size="1" width="70%" align="left">
      <font face="Times New Roman, Times, Serif" size=2>Name: Dennis O&#146;Conner
      <br>
      Title: VP - CFO </font></TD>
  </TR>
  <TR VALIGN=TOP>
    <TD WIDTH=47%>&nbsp;</TD>
    <TD WIDTH=4%>&nbsp;</TD>
    <TD WIDTH=49%>
      <p>&nbsp;</p>
      <p>&nbsp;</p>
    </TD>
  </TR>
  <TR VALIGN=TOP>
    <TD WIDTH=47%>&nbsp;</TD>
    <TD colspan="2">
      <p><font face="Times New Roman, Times, Serif" size=2>QUINTILES IRELAND LIMITED
        </font></p>
      <p>&nbsp;</p>
    </TD>
  </TR>
  <TR VALIGN=TOP>
    <TD WIDTH=47%>&nbsp;</TD>
    <TD WIDTH=4%><font face="Times New Roman, Times, Serif" size=2>By:</font></TD>
    <TD WIDTH=49%><font face="Times New Roman, Times, Serif" size=2> /s/ Marie
      Kenny <br>
      </font>
      <hr noshade size="1" width="70%" align="left">
      <font face="Times New Roman, Times, Serif" size=2>Name: Marie Kenny <br>
      Title: Director </font></TD>
  </TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Page Break CENTER" FSL="Workstation" -->
<BR>
<TABLE WIDTH=100%><TR><TD WIDTH=20% ALIGN=left><FONT SIZE=1>&nbsp;</FONT></TD><TD WIDTH=60% ALIGN=center><FONT SIZE="2">
</FONT></TD><TD WIDTH=20% ALIGN=right><FONT SIZE="1">&nbsp;</FONT></TD></TR></TABLE><HR ALIGN=LEFT WIDTH=100% SIZE=5 noshade><BR>

</BODY>
</HTML>


</TEXT>
</DOCUMENT>
